Last week I attended my first NSF ATE PI meeting. As a contributing member of Digital World Biology's ATE project entitled " A Bridge to Bio-Link's Future ," I participated in the conference by preparing and staffing our booth in the first evening's showcase.
As a brief background, the NSF (National Science Foundation) ATE (Advanced Technology Eduction) program celebrated its 25 th anniversary this year. ATE's mission is to support innovations in technical ... Read more
A simple web search says biotech is really big. One estimate indicates that the industry will have $400 billion in sales in 2017 with growth to over $775 billion by 2024 [1]. Another report suggests there are over 77,000 employers [2]. That’s big, but is it real, and what you can do with this information?
At Biotech-Careers.org we're interested in helping students and graduates of biotech programs at community and four-year colleges learn about the multitude of opportunities available in the biotech industry. To be helpful we ... Read more
A simple web search says biotech is really big. One estimate indicates that the industry will have $400 billion in sales in 2017 with growth to over $775 billion by 2024 [1]. Another report suggests there are over 77,000 employers [2]. That’s big, but is it real, and what you can do with this information?
Worldwide locations of biotechnology employers. Source Biotech- ... Read more
I learned via e-mail yesterday that the biotechnology program, that I taught with for ten years during the 90's, is ending due to low enrollments.
I also learned yesterday, via the Seattle Times, that a resurrected version of ICOS called CMC Icos Biologics is planning a $35M expansion of their biotech manufacturing plant in Bothell and talking about hiring lots of students with two-year degrees.
The irony isn't lost on me.
We struggled with variable enrollments too, when I was at Seattle Central ... Read more
Workforce shortages are a growing problem in the biotech industry. Communities are concerned that a lack of trained workers will either keep companies away or cause companies to move. If companies do have to move, it's likely those jobs might be lost forever, never to return. According to Robert Reich, former U.S. secretary of labor, now a professor at UC-Berkeley, biotech companies that can't hire in the U.S. will recruit foreign workers or open research centers overseas (Luke Timmerman, Seattle PI).
... Read more
